Danielle R. Mercatante, Ph.D. - Publications

Affiliations: 
2002 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacology, Oncology, Cell Biology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Bristow CL, Mercatante DR, Kole R. HIV-1 preferentially binds receptors copatched with cell-surface elastase. Blood. 102: 4479-86. PMID 12933574 DOI: 10.1182/Blood-2003-05-1635  0.516
2003 Ghio AJ, Nozik-Grayck E, Turi J, Jaspers I, Mercatante DR, Kole R, Piantadosi CA. Superoxide-dependent iron uptake: a new role for anion exchange protein 2. American Journal of Respiratory Cell and Molecular Biology. 29: 653-60. PMID 12791678 DOI: 10.1165/Rcmb.2003-0070Oc  0.527
2002 Mercatante DR, Mohler JL, Kole R. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. The Journal of Biological Chemistry. 277: 49374-82. PMID 12381725 DOI: 10.1074/Jbc.M209236200  0.63
2002 Mercatante DR, Kole R. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression. Biochimica Et Biophysica Acta. 1587: 126-32. PMID 12084454 DOI: 10.1016/S0925-4439(02)00075-3  0.636
2001 Mercatante DR, Sazani P, Kole R. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases. Current Cancer Drug Targets. 1: 211-30. PMID 12188880  0.64
2001 Mercatante DR, Bortner CD, Cidlowski JA, Kole R. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. The Journal of Biological Chemistry. 276: 16411-7. PMID 11278482 DOI: 10.1074/Jbc.M009256200  0.641
2000 Gorman L, Mercatante DR, Kole R. Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs. The Journal of Biological Chemistry. 275: 35914-9. PMID 10969081 DOI: 10.1074/Jbc.M006259200  0.589
2000 Mercatante D, Kole R. Modification of alternative splicing pathways as a potential approach to chemotherapy Pharmacology and Therapeutics. 85: 237-243. PMID 10739878 DOI: 10.1016/S0163-7258(99)00067-4  0.667
Show low-probability matches.